Role of reactive oxygen species in neonatal pulmonary vascular disease

Antioxidants and Redox Signaling

Volumn 21, Issue 13, 2014, Pages 1926-1942

  Wedgwood, Stephen ^a   Steinhorn, Robin H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VASODILATOR AGENT;

ARTICLE; DISEASE SEVERITY; HUMAN; HYPEROXIA; HYPOXIA; LUNG DEVELOPMENT; LUNG INJURY; MITOCHONDRION; NEONATAL PULMONARY VASCULAR DISEASE; NEWBORN; NEWBORN DISEASE; OUTCOME ASSESSMENT; PERINATAL DEVELOPMENT; PERSISTENT PULMONARY HYPERTENSION; PULMONARY ARTERY; PULMONARY VASCULAR DISEASE; RESPIRATORY CHAIN; ANIMAL; LUNG; LUNG DYSPLASIA; METABOLISM; PULMONARY HYPERTENSION; VASCULAR DISEASE; VASCULARIZATION;

ANIMALIA;

ANIMALS; ANIMALS, NEWBORN; BRONCHOPULMONARY DYSPLASIA; HUMANS; HYPERTENSION, PULMONARY; INFANT, NEWBORN; LUNG; PULMONARY ARTERY; REACTIVE OXYGEN SPECIES; VASCULAR DISEASES;

EID: 84911875444     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5785     Document Type: Article

References (197)

1. Abman SH. Impaired vascular endothelial growth factor signaling in the pathogenesis of neonatal pulmonary vascular disease. Adv Exp Med Biol 661: 323-335, 2010.
2. Abman SH, Shanley PF, and Accurso FJ. Failure of postnatal adaptation of the pulmonary circulation after chronic intrauterine pulmonary hypertension in fetal lambs. J Clin Invest 83: 1849-1858, 1989.
3. Afolayan AJ, Eis A, Teng RJ, Bakhutashvili I, Kaul S, Davis JM, and Konduri GG. Decreases in manganese superoxide dismutase expression and activity contribute to oxidative stress in persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 303: L870-L879, 2012.
4. Afshar S, Gibson LL, Yuhanna IS, Sherman TS, Kerecman JD, Grubb PH, Yoder BA, McCurnin DC, and Shaul PW. Pulmonary NO synthase expression is attenuated in a fetal baboon model of chronic lung disease. Am J Physiol Lung Cell Mol Physiol 284: L749-L758, 2003.
5. Ahmed MN, Suliman HB, Folz RJ, Nozik-Grayck E, Golson ML, Mason SN, and Auten RL. Extracellular superoxide dismutase protects lung development in hyperoxia- exposed newborn mice. Am J Respir Crit Care Med 167: 400-405, 2003.
6. Altenhofer S, Kleikers PW, Radermacher KA, Scheurer P, Rob Hermans JJ, Schiffers P, Ho H, Wingler K, and Schmidt HH. The NOX toolbox: validating the role of NADPH oxidases in physiology and disease. Cell Mol Life Sci 69: 2327-2343, 2012.
7. Ambalavanan N, Bulger A, Murphy-Ullrich J, Oparil S, and Chen Y. Endothelin-A receptor blockade prevents and partially reverses neonatal hypoxic pulmonary vascular remodeling. Pediatr Res 57: 631-636, 2005.
8. An HS, Bae EJ, Kim GB, Kwon BS, Beak JS, Kim EK, Kim HS, Choi JH, Noh CI, and Yun YS. Pulmonary hypertension in preterm infants with bronchopulmonary dysplasia. Korean Circ J 40: 131-136, 2010.
9. Ananthakrishnan M, Barr FE, Summar ML, Smith HA, Kaplowitz M, Cunningham G, Magarik J, Zhang Y, and Fike CD. L-Citrulline ameliorates chronic hypoxiainduced pulmonary hypertension in newborn piglets. Am J Physiol Lung Cell Mol Physiol 297: L506-L511, 2009.
10. Angus DC, Linde-Swirble WT, Clermont G, Griffin MF, and Clark RH. Epidemiology of neonatal respiratory failure in the United States. Am J Resp Crit Care Med 164: 1154-1160, 2001.
11. Ardanaz N, Yang XP, Cifuentes ME, Haurani MJ, Jackson KW, Liao TD, Carretero OA, and Pagano PJ. Lack of glutathione peroxidase 1 accelerates cardiac-specific hypertrophy and dysfunction in angiotensin II hypertension. Hypertension 55: 116-123, 2010.
12. Asikainen TM and White CW. Pulmonary antioxidant defenses in the preterm newborn with respiratory distress and bronchopulmonary dysplasia in evolution: implications for antioxidant therapy. Antioxid Redox Signal 6: 155-167, 2004.
13. Balasubramaniam V, Maxey AM, Morgan DB, Markham NE, and Abman SH. Inhaled NO restores lung structure in eNOS-deficient mice recovering fromneonatal hypoxia. Am J Physiol Lung Cell Mol Physiol 291: L119-L127, 2006.
14. Balasubramaniam V, Tang JR, Maxey A, Plopper CG, and Abman SH. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol 284: L964-L971, 2003.
15. Belik J, Pan J, Jankov R, and Tanswell A. Peroxynitrite inhibits relaxation and induces pulmonary artery muscle contraction in the newborn rat. Free Radic Biol Med 37: 1384-1392, 2004.
16. Berkelhamer S, Mestan KK, and Steinhorn RH. Pulmonary hypertension in bronchopulmonary dysplasia. Semin Perinatol 37: 124-131, 2013.
17. Berkelhamer SK, Kim GA, Radder JE, Wedgwood S, Czech L, Steinhorn RH, and Schumacker PT. Developmental differences in hyperoxia-induced oxidative stress and cellular responses in the murine lung. Free Radic Biol Med 61C: 51-60, 2013.
18. Bhat R, Salas AA, Foster C, Carlo WA, and Ambalavanan N. Prospective analysis of pulmonary hypertension in extremely low birth weight infants. Pediatrics 129: e682- e689, 2012.
19. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, and Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164: 1971-1980, 2001.
20. Black S, DeVol J, and Wedgwood S. Regulation of fibroblast growth factor-2 expression in pulmonary arterial smooth muscle cells involves increased reactive oxygen species generation. Am J Physiol Cell Physiol 294: C345- C354, 2008.
21. Black SM, Johengen MJ, and Soifer SJ. Coordinated regulation of genes of the nitric oxide and endothelin pathways during the development of pulmonary hypertension in fetal lambs. Pediatr Res 44: 821-830, 1998.
22. Brennan LA, Steinhorn RH, Wedgwood S, Mata- Greenwood E, Roark EA, Russell JA, and Black SM. Increased superoxide generation is associated with pulmonary hypertension in fetal lambs: a role for NADPH oxidase. Circ Res 92: 683-691, 2003.
23. Brown DI and Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 47: 1239-1253, 2009.
24. Carnesecchi S, Deffert C, Pagano A, Garrido-Urbani S, Metrailler-Ruchonnet I, Schappi M, Donati Y, Matthay MA, Krause KH, and Barazzone Argiroffo C. NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. Am J Respir Crit Care Med 180: 972-981, 2009.
25. Chambers CD, Hernandez-Diaz S, Van Marter LJ, Werler MM, Louik C, Jones KL, and Mitchell AA. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354: 579-587, 2006.
26. Chamseddine AH and Miller FJ, Jr. Gp91phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells. Am J Physiol Heart Circ Physiol 285: H2284-H2289, 2003.
27. Chandrasekar I, Eis A, and Konduri GG. Betamethasone attenuates oxidant stress in endothelial cells from fetal lambs with persistent pulmonary hypertension. Pediatr Res 63: 67-72, 2008.
28. Check J, Gotteiner N, Liu X, Su E, Porta N, Steinhorn R, and Mestan KK. Fetal growth restriction and pulmonary hypertension in premature infants with bronchopulmonary dysplasia. J Perinatol 33: 553-557, 2013.
29. Chen B, Calvert AE, Cui H, and Nelin LD. Hypoxia promotes human pulmonary artery smooth muscle cell proliferation through induction of arginase. Am J Physiol Lung Cell Mol Physiol 297: L1151-L1159, 2009.
30. Chen K, Kirber MT, Xiao H, Yang Y, and Keaney JF, Jr. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J Cell Biol 181: 1129-1139, 2008.
31. Chester M, Tourneux P, Seedorf G, Grover TR, Gien J, and Abman SH. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 297: L318-L325, 2009.
32. Clarke MB, Wright R, Irwin D, Bose S, Van Rheen Z, Birari R, Stenmark KR, McCord JM, and Nozik-Grayck E. Sustained lung activity of a novel chimeric protein, SOD2/3, after intratracheal administration. Free Radic Biol Med 49: 2032-2039, 2010.
33. Clerch LB and Massaro D. Rat lung antioxidant enzymes: differences in perinatal gene expression and regulation. Am J Physiol 263: L466-L470, 1992.
34. Coggins MP and Bloch KD. Nitric oxide in the pulmonary vasculature. Arterioscler Thromb Vasc Biol 27: 1877-1885, 2007.
35. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, and Carmeliet P. Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 8: 702-710, 2002.
36. Csanyi G, Taylor WR, and Pagano PJ. NOX and inflammation in the vascular adventitia. Free Radic Biol Med 47: 1254-1266, 2009.
37. Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W, and North American Recombinant Human CuZnSOD Study Group. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics 111: 469-476, 2003.
38. Dawes GS, Mott JC, Widdicombe JG, and Wyatt DG. Changes in the lungs of the newborn lamb. J Physiol 121: 141-162, 1953.
39. de Visser YP, Walther FJ, Laghmani el H, Boersma H, van der Laarse A, and Wagenaar GT. Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury. Respir Res 10: 30, 2009.
40. Delaney C, Gien J, Grover TR, Roe G, and Abman SH. Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus. Am J Physiol Lung Cell Mol Physiol 301: L937-L944, 2011.
41. Delaney C, Gien J, Roe G, Isenberg N, Kailey J, and Abman SH. Serotonin contributes to high pulmonary vascular tone in a sheep model of persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 304: L894-L901, 2013.
42. Dennis KE, Aschner JL, Milatovic D, Schmidt JW, Aschner M, Kaplowitz MR, Zhang Y, and Fike CD. NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets. Am J Physiol Lung Cell Mol Physiol 297: L596-L607, 2009.
43. Diebold I, Petry A, Hess J, and Görlach A. The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia- inducible factor-1. Mol Biol Cell 21: 2087-2096, 2010.
44. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med 51: 1289-1301, 2011.
45. Dikalov S, Dikalova A, Bikineyeva A, Schmidt H, Harrison D, and Griendling K. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radic Biol Med 45: 1340-1351, 2008.
46. Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG, and Dikalov SI. Therapeutic targeting of mitochondrial superoxide in hypertension. Circ Res 107: 106-116, 2010.
47. Dikalova AE, Gongora MC, Harrison DG, Lambeth JD, Dikalov S, and Griendling KK. Upregulation of Nox1 in vascular smooth muscle leads to impaired endotheliumdependent relaxation via eNOS uncoupling. Am J Physiol Heart Circ Physiol 299: H673-H679, 2010.
48. Djonov V, Schmid M, Tschanz SA, and Burri PH. Intussusceptive angiogenesis: its role in embryonic vascular network formation. Circ Res 86: 286-292, 2000.
49. Djordjevic T, BelAiba RS, Bonello S, Pfeilschifter J, Hess J, and Gorlach A. Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler Thromb Vasc Biol 25: 519-525, 2005.
50. Dunn JA, Lorch V, and Sinha SN. Responses of small intrapulmonary arteries to vasoactive compounds in the fetal and neonatal lamb: norepinephrine, epinephrine, serotonin, and potassium chloride. Pediatr Res 25: 360-363, 1989.
51. Eddahibi S, Raffestin B, Pham I, Launay JM, Aegerter P, Sitbon M, and Adnot S. Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats. Am J Physiol 272: H1173-H1181, 1997.
52. Fagan KA, Fouty BW, Tyler RC, Morris KG, Jr., Hepler LK, Sato K, LeCras TD, Abman SH, Weinberger HD, Huang PL, McMurtry IF, and Rodman DM. The pulmonary circulation of homozygous or heterozygous eNOSnull mice is hyperresponsive to mild hypoxia. J Clin Invest 103: 291-299, 1999.
53. Fagan KA, Oka M, Bauer NR, Gebb SA, Ivy DD, Morris KG, and McMurtry IF. Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287: L656-L664, 2004.
54. Farrell MR, Rogers LK, Liu Y, Welty SE, and Tipple TE. Thioredoxin-interacting protein inhibits hypoxia-inducible factor transcriptional activity. Free Radic Biol Med 49: 1361-1367, 2010.
55. Farrow K, Wedgwood S, Lee K, Czech L, Gugino S, Lakshminrusimha S, Schumacker P, and Steinhorn R. Mitochondrial oxidant stress increases PDE5 activity in persistent pulmonary hypertension of the newborn. Respir Physiol Neurobiol 174: 272-281, 2010.
56. Farrow KN, Fliman P, and Steinhorn RH. The diseases treated with ECMO: focus on PPHN. Semin Perinatol 29: 8-14, 2005.
57. Farrow KN, Groh BS, Schumacker PT, Lakshminrusimha S, Czech L, Gugino SF, Russell JA, and Steinhorn RH. Hyperoxia increases phosphodiesterase 5 expression and activity in ovine fetal pulmonary artery smooth muscle cells. Circ Res 102: 226-233, 2008.
58. Farrow KN, Lakshminrusimha S, Czech L, Groh BS, Gugino S, Davis JM, Russell JA, and Steinhorn RH. SOD and inhaled nitric oxide normalize phosphodiesterase 5 expression and activity in neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 299: L109-L116, 2010.
59. Farrow KN, Lakshminrusimha S, Reda WJ, Wedgwood S, Czech L, Gugino SF, Davis JM, Russell JA, and Steinhorn RH. Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 295: L979-L987, 2008
60. Fike CD, Dikalova A, Slaughter JC, Kaplowitz MR, Zhang Y, and Aschner JL. Reactive oxygen species-reducing strategies improve pulmonary arterial responses to nitric oxide in piglets with chronic hypoxia-induced pulmonary hypertension. Antioxid Redox Signal 18: 1727-1738, 2013.
61. Fike CD, Kaplowitz MR, Rehorst-Paea LA, and Nelin LD. L-Arginine increases nitric oxide production in isolated lungs of chronically hypoxic newborn pigs. J Appl Physiol 88: 1797-1803, 2000.
62. Fike CD, Kaplowitz MR, Thomas CJ, and Nelin LD. Chronic hypoxia decreases nitric oxide production and endothelial nitric oxide synthase in newborn pig lungs. Am J Physiol 274: L517-L526, 1998.
63. Fike CD, Slaughter JC, Kaplowitz MR, Zhang Y, and Aschner JL. Reactive oxygen species from NADPH oxidase contribute to altered pulmonary vascular responses in piglets with chronic hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 295: L881- L888, 2008.
64. Fineman JR, Soifer SJ, and Heymann MA. Regulation of pulmonary vascular tone in the perinatal period. Ann Rev Physiol 57: 115-134, 1995.
65. Fornaro E, Li D, Pan J, and Belik J. Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat. Am J Respir Crit Care Med 176: 1035-1040, 2007.
66. Fukai T, Folz RJ, Landmesser U, and Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55: 239-249, 2002.
67. Fukui T, Lassegue B, Kai H, Alexander RW, and Griendling KK. Cytochrome b-558 alpha-subunit cloning and expression in rat aortic smooth muscle cells. Biochim Biophys Acta 1231: 215-219, 1995.
68. Furchgott RF and Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2018, 1989.
69. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, and Ferrara N. VEGF is required for growth and survival in neonatal mice. Development 126: 1149-1159, 1999.
70. Gien J, Seedorf GJ, Balasubramaniam V, Markham N, and Abman SH. Intrauterine pulmonary hypertension impairs angiogenesis in vitro: role of vascular endothelial growth factor nitric oxide signaling. Am J Respir Crit Care Med 176: 1146-1153, 2007.
71. Gien J, Seedorf GJ, Balasubramaniam V, Tseng N, Markham N, and Abman SH. Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitro. Am J Physiol Lung Cell Mol Physiol 295: L680-L687, 2008.
72. Gien J, Tseng N, Seedorf G, Roe G, and Abman SH. Endothelin-1 impairs angiogenesis in vitro through Rhokinase activation after chronic intrauterine pulmonary hypertension in fetal sheep. Pediatr Res 73: 252-262, 2013.
73. Green DE, Murphy TC, Kang BY, Kleinhenz JM, Szyndralewiez C, Page P, Sutliff RL, and Hart CM. The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation. Am J Respir Cell Mol Biol 47: 718-726, 2012.
74. Grover TR, Parker TA, Zenge JP, Markham NE, Kinsella JP, and Abman SH. Intrauterine hypertension decreases lung VEGF expression and VEGF inhibition causes pulmonary hypertension in the ovine fetus. Am J Physiol Lung Cell Mol Physiol 284: L508-L517, 2003.
75. Guzy RD and Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91: 807-819, 2006.
76. Hall SM, Hislop AA, Pierce CM, and Haworth SG. Prenatal origins of human intrapulmonary arteries: formation and smooth muscle maturation. Am J Respir Cell Mol Biol 23: 194-203, 2000.
77. Han RN, Babaei S, Robb M, Lee T, Ridsdale R, Ackerley C, Post M, and Stewart DJ. Defective lung vascular development and fatal respiratory distress in endothelial NO synthase-deficient mice: a model of alveolar capillary dysplasia? Circ Res 94: 1115-1123, 2004.
78. Hassoun PM, Thappa V, Landman MJ, and Fanburg BL. Endothelin 1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Exp Bio Med 199: 165-170, 1992.
79. Haworth S and Reid L. Persistent fetal circulation: newly recognized structural features. J Pediatr 88: 614-620, 1976.
80. Haworth SG. Pulmonary vascular disease in different types of congenital heart disease:implications for interpretation of lung biopsy findings in early childhood. Br Heart J 52: 557-571, 1984.
81. Heath D and Edwards JE. The pathology of hypertensive pulmonary vascular disease: a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation 18: 533-547, 1958.
82. Herrera EA, Pulgar VM, Riquelme RA, Sanhueza EM, Reyes RV, Ebensperger G, Parer JT, Valdez EA, Giussani DA, Blanco CE, Hanson MA, and Llanos AJ. Highaltitude chronic hypoxia during gestation and after birth modifies cardiovascular responses in newborn sheep. Am J Physiol Regul Integr Comp Physiol 292: R2234-R2240, 2007.
83. Hislop A, Haworth SG, and Reid L. Quantitative structural analysis of pulmonary vessels in isolated ventricular septal defects in infancy. Br Heart J 37: 1014-1021, 1975.
84. Hislop AA and Haworth SG. Pulmonary vascular damage and the development of cor pulmonale following hyaline membrane disease. Pediatr Pulmonol 9: 152-161, 1990.
85. Ho YS, Xiong Y, Ma W, Spector A, and Ho DS. Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 279: 32804-32812, 2004.
86. Hoffman JIE, Rudolph AM, and Heymann MA. Pulmonary vascular disease with congenital heart lesions: pathologic features and causes. Circulation 64: 873-877, 1981.
87. Hosford GE and Olson DM. Effects of hyperoxia on VEGF, its receptors, and HIF-2alpha in the newborn rat lung. Am J Physiol Lung Cell Mol Physiol 285: L161- L168, 2003.
88. Ivy DD, Parker TA, Ziegler JW, Galan HL, Kinsella JP, Tuder RM, and Abman SH. Prolonged endothelin A receptor blockade attenuates chronic pulmonary hypertension in the ovine fetus. J Clin Invest 99: 1179-1186, 1997.
89. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, and Abman SH. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279: L600-L607, 2000.
90. Jin Y, Calvert TJ, Chen B, Chicoine LG, Joshi M, Bauer JA, Liu Y, and Nelin LD. Mice deficient in Mkp-1 develop more severe pulmonary hypertension and greater lung protein levels of arginase in response to chronic hypoxia. Am J Physiol Heart Circ Physiol 298: H1518- H1528, 2010.
91. Kamezaki F, Tasaki H, Yamashita K, Tsutsui M, Koide S, Nakata S, Tanimoto A, Okazaki M, Sasaguri Y, Adachi T, and Otsuji Y. Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats. Am J Respir Crit Care Med 177: 219-226, 2008.
92. Keller RL, Tacy TA, Hendricks-Munoz K, Xu J, Moon-Grady AJ, Neuhaus J, Moore P, Nobuhara KK, Hawgood S, and Fineman JR. Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. Am J Respir Crit Care Med 182: 555-561, 2010.
93. Khemani E, McElhinney DB, Rhein L, Andrade O, Lacro RV, Thomas KC, and Mullen MP. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics 120: 1260-1269, 2007.
94. Khoo JP, Zhao L, Alp NJ, Bendall JK, Nicoli T, Rockett K, Wilkins MR, and Channon KM. Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension. Circulation 111: 2126-2133, 2005.
95. Kim YM, Barnes EA, Alvira CM, Ying L, Reddy S, and Cornfield DN. Hypoxia-inducible factor-1alpha in pulmonary artery smooth muscle cells lowers vascular tone by decreasing Myosin light chain phosphorylation. Circ Res 112: 1230-1233, 2013.
96. Kimura S, Egashira K, Chen L, Nakano K, Iwata E, Miyagawa M, Tsujimoto H, Hara K, Morishita R, Sueishi K, Tominaga R, and Sunagawa K. Nanoparticle-mediated delivery of nuclear factor kappaB decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension. Hypertension 53: 877-883, 2009
97. Konduri G, Solimano A, Sokol G, Singer J, Ehrenkranz R, Singhal N, Wright L, Van Meurs K, Stork E, Kirpalani H, and Peliowski A. A randomized trial of early vs. standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure. Pediatrics 113: 559-564, 2004.
98. Koppel R, Han RN, Cox D, Tanswell AK, and Rabinovitch M. Alpha 1-antitrypsin protects neonatal rats from pulmonary vascular and parenchymal effects of oxygen toxicity. Pediatr Res 36: 763-770, 1994.
99. Kumar P, Kazzi NJ, and Shankaran S. Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn. Am J Perinatol 13: 335-341, 1996.
100. Kuo CY. Endothelin-A receptor antagonist prevents neonatal pulmonary hypertension in meconium aspiration in piglets. J Formos Med Assoc 100: 420-423, 2001.
101. Kuroda J, Nakagawa K, Yamasaki T, Nakamura K, Takeya R, Kuribayashi F, Imajoh-Ohmi S, Igarashi K, Shibata Y, Sueishi K, and Sumimoto H. The superoxideproducing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells 10: 1139-1151, 2005.
102. Ladha F, Bonnet S, Eaton F, Hashimoto K, Korbutt G, and Thebaud B. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Am J Respir Crit Care Med 172: 750-756, 2005.
103. Lakshminrusimha S, Russell J, Wedgwood S, Gugino S, Kazzaz J, Davis J, and Steinhorn RH. Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med 174: 1370-1377, 2006.
104. Lakshminrusimha S, Russell JA, Steinhorn RH, Swartz DD, Ryan RM, Gugino SF, Wynn KA, Kumar VH, Mathew B, Kirmani K, and Morin FC, 3rd. Pulmonary hemodynamics in neonatal lambs resuscitated with 21%, 50%, and 100% oxygen. Pediatr Res 62: 313-318, 2007.
105. Lakshminrusimha S, Steinhorn RH, Wedgwood S, Savorgnan F, Nair J, Mathew B, Gugino SF, Russell JA, and Swartz DD. Pulmonary hemodynamics and vascular reactivity in asphyxiated term lambs resuscitated with 21 and 100% oxygen. J Appl Physiol 111: 1441-1447, 2011.
106. Lakshminrusimha S, Swartz DD, Gugino SF, Ma CX, Wynn KA, Ryan RM, Russell JA, and Steinhorn RH. Oxygen concentration and pulmonary hemodynamics in newborn lambs with pulmonary hypertension. Pediatr Res 66: 539-544, 2009.
107. Landmesser U, Dikalov S, Price SR, McCann L, Fukai T, Holland SM, Mitch WE, and Harrison DG. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest 111: 1201-1209., 2003.
108. Lassegue B and Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297, 2003.
109. Lassegue B and Griendling KK. NADPH Oxidases: Functions and Pathologies in the Vasculature. Arterioscler Thromb Vasc Biol 30: 653-661, 2009.
110. Lassegue B and Griendling KK. Reactive oxygen species in hypertension; An update. Am J Hypertens 17: 852-860, 2004.
111. Lassus P, Turanlahti M, Heikkila P, Andersson LC, Nupponen I, Sarnesto A, and Andersson S. Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 164: 1981-1987, 2001.
112. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, and Abman SH. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 283: L555-L562, 2002.
113. Li L, Shoji W, Takano H, Nishimura N, Aoki Y, Takahashi R, Goto S, Kaifu T, Takai T, and Obinata M. Increased susceptibility of MER5 (peroxiredoxin III) knockout mice to LPS-induced oxidative stress. Biochem Biophys Res Commun 355: 715-721, 2007.
114. Lin YJ, Markham NE, Balasubramaniam V, Tang JR, Maxey A, Kinsella JP, and Abman SH. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 58: 22-29, 2005.
115. Liu J, Zelko I, Erbynn E, Sham J, and Folz R. Hypoxic pulmonary hypertension: role of superoxide and NADPH oxidase (gp91phox). Am J Physiol Lung Cell Mol Physiol 290: L2-L10, 2006.
116. Lopez E, Boucherat O, Franco-Montoya ML, Bourbon JR, Delacourt C, and Jarreau PH.Nitric oxide donor restores lung growth factor and receptor expression in hyperoxia-exposed rat pups. Am J Respir Cell Mol Biol 34: 738-745, 2006.
117. Lyle AN, Deshpande NN, Taniyama Y, Seidel-Rogol B, Pounkova L, Du P, Papaharalambus C, Lassegue B, and Griendling KK. Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells. Circ Res 105: 249-259, 2009.
118. Madamanchi NR and Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res 100: 460-473, 2007.
119. Mamo LB, Suliman HB, Giles BL, Auten RL, Piantadosi CA, and Nozik-Grayck E. Discordant extracellular superoxide dismutase expression and activity in neonatal hyperoxic lung. Am J Respir Crit Care Med 170: 313-318, 2004.
120. Manchester D, Margolis HS, and Sheldon RE. Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn. Am J Obstet Gynecol 126: 467-469, 1976.
121. Manea A, Manea S, Gafencu A, and Raicu M. Regulation of NADPH oxidase subunit p22(phox) by NF-kB in human aortic smooth muscle cells. Arch Physiol Biochem 113: 163-172, 2007.
122. Manea A, Tanase L, Raicu M, and Simionescu M. Transcriptional regulation of NADPH oxidase isoforms, Nox1 and Nox4, by nuclear factor-kappaB in human aortic smooth muscle cells. Biochem Biophy Res Commun 396: 901-907, 2010.
123. Maniscalco WM, Watkins RH, D'Angio CT, and Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 16: 557-567, 1997.
124. Masood A, Belcastro R, Li J, Kantores C, Jankov RP, and Tanswell AK. A peroxynitrite decomposition catalyst prevents 60% O2-mediated rat chronic neonatal lung injury. Free Radic Biol Med 49: 1182-1191, 2010.
125. Masri F, Comhair S, Dostanic-Larson I, Kaneko F, Dweik R, Arroliga A, and Erzurum S. Deficiency of lung antioxidants in idiopathic pulmonary arterial hypertension. Clin Transl Sci 1: 99-106, 2008.
126. Meyrick B and Reid L. Ultrastructural findings in lung biopsy material from children with congenital heart defects. Am J Pathol 101: 527-537, 1980.
127. Mittal M, Roth M, Konig P, Hofmann S, Dony E, Goyal P, Selbitz AC, Schermuly RT, Ghofrani HA, Kwapiszewska G, Kummer W, Klepetko W, Hoda MA, Fink L, Hanze J, Seeger W, Grimminger F, Schmidt HH, and Weissmann N. Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature. Circ Res 101: 258-267, 2007.
128. Morin III FC. Ligating the ductus arteriosus before birth causes persistent pulmonary hypertension in the newborn lamb. Pediatr Res 25: 245-250, 1989.
129. Murphy JD, Vawter GF, and Reid LM. Pulmonary vascular disease in fatal meconium aspiration. J Pediatr 104: 758-762, 1984.
130. Nakamura K, Koga Y, Sakai H, Homma K, and Ikebe M. cGMP-dependent relaxation of smooth muscle is coupled with the change in the phosphorylation of myosin phosphatase. Circ Res 101: 712-722, 2007.
131. Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH, and Van Etten RA. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature 424: 561-565, 2003.
132. Niermeyer S. Cardiopulmonary transition in the high altitude infant. High Alt Med Biol 4: 225-239, 2003.
133. Nozik-Grayck E, Suliman H, Majka S, Albietz J, Van Rheen Z, Roush K, and Stenmark K. Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 295: L422-L430, 2008.
134. Oury TD, Chang L, Marklund S, Day BJ, and Crapo JD. Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest 70: 889-898, 1994.
135. Oury TD, Day BJ, and Crapo JD. Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic Biol Med 20: 957-965, 1996.
136. Pan L, Fu JH, Xue XD, Xu W, Zhou P, and Wei B. Melatonin protects against oxidative damage in a neonatal rat model of bronchopulmonary dysplasia. World J Pediatr 5: 216-221, 2009.
137. Parker TA, Roe G, Grover TR, and Abman SH. Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 291: L976-L982, 2006.
138. Patil S, Bunderson M, Wilham J, and Black SM. Important role for Rac1 in regulating reactive oxygen species generation and pulmonary arterial smooth muscle cell growth. Am J Physiol Lung Cell Mol Physiol 287: L1314- L1322, 2004.
139. Perez M, Lakshminrusimha S, Wedgwood S, Czech L, Gugino SF, Russell JA, Farrow KN, and Steinhorn RH. Hydrocortisone normalizes oxygenation and cGMP regulation in lambs with persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 302: L595-L603, 2012.
140. Perreault T, Berkenbosch JW, Barrington KJ, Decker ER, Wu C, Brock TA, and Baribeau J. TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets. Pediatr Res 50: 374-383, 2001.
141. Perveen S, Patel H, Arif A, Younis S, Codipilly CN, and Ahmed M. Role of EC-SOD overexpression in preserving pulmonary angiogenesis inhibited by oxidative stress. PLoS One 7: e51945, 2012.
142. Petry A, Djordjevic T, Weitnauer M, Kietzmann T, Hess J, and Gorlach A. NOX2 and NOX4 mediate proliferative response in endothelial cells. Antioxid Redox Signal 8: 1473-1484, 2006.
143. Qin Z, Reszka KJ, Fukai T, and Weintraub NL. Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD. Transl Res 151: 68-78, 2008.
144. Rabinovitch M, Haworth SG, Castaneda AR, Nadas AS, and Reid LM. Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation 58: 1107-1122, 1978.
145. Rajatapiti P, van der Horst IW, de Rooij JD, Tran MG, Maxwell PH, Tibboel D, Rottier R, and de Krijger RR. Expression of hypoxia-inducible factors in normal human lung development. Pediatr Dev Pathol 11: 193-199, 2008.
146. Rao G and Berk B. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 18: 775-794, 1992.
147. Rathore R, Zheng YM, Niu CF, Liu QH, Korde A, Ho YS, and Wang YX. Hypoxia activates NADPH oxidase to increase [ROS]i and [Ca2 + ]i through the mitochondrial ROS-PKCepsilon signaling axis in pulmonary artery smooth muscle cells. Free Radic Biol Med 45: 1223-1231, 2008.
148. Rhee SG, Chae HZ, and Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38: 1543-1552, 2005.
149. Rhoades R, Packer C, Roepke D, Jin N, and Meiss R. Reactive oxygen species alter contractile properties of pulmonary arterial smooth muscle. Can J Physiol Pharmacol 68: 1581-1589, 1990.
150. Robbins IM, Hemnes AR, Gibbs JS, Christman BW, Howard L, Meehan S, Cabrita I, Gonzalez R, Oyler T, Zhao L, Du RH, Mendes LA, and Wilkins MR. Safety of sapropterin dihydrochloride (6r-bh4) in patients with pulmonary hypertension. Exp Lung Res 37: 26-34, 2011.
151. Rodriguez-Iturbe B, Sepassi L, Quiroz Y, Ni Z, Wallace DC, and Vaziri ND. Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence. J Appl Physiol 102: 255-260, 2007.
152. Rozance PJ, Seedorf GJ, Brown A, Roe G, O'Meara MC, Gien J, Tang JR, and Abman SH. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol 301: L860-L871, 2011.
153. Saugstad OD. Oxygen and oxidative stress in bronchopulmonary dysplasia. J Perinat Med 38: 571-577, 2010.
154. Sawada H, Mitani Y, Maruyama J, Jiang B, Ikeyama Y, Dida F, Yamamoto H, Imanka-Yoshida K, Shimpo H, Mizoguchi A, Maruyama K, and Komada Y. A nuclear factor-kappaB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. Chest 132: 1265-1274, 2007.
155. Schneider R, Raff U, Vornberger N, Schmidt M, Freund R, Reber M, Schramm L, Gambaryan S, Wanner C, Schmidt HH, and Galle J. L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats. Kidney Int 64: 216-225, 2003.
156. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Forro L, Schlegel W, and Krause K. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406: 105-114, 2007.
157. Shaul PW, Yuhanna IS, German Z, Chen Z, Steinhorn RH, and Morin III FC. Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension. Am J Physiol 272: L1005-L1012, 1997.
158. Steinhorn RH. Neonatal pulmonary hypertension. Pediatr Crit Care Med 11: S79-S84, 2010.
159. Stenmark KR, Yeager ME, El Kasmi KC, Nozik-Grayck E, Gerasimovskaya EV, Li M, Riddle SR, and Frid MG. The adventitia: essential regulator of vascular wall structure and function. Annu Rev Physiol 75: 23-47, 2013.
160. Sturrock A, Cahill B, Norman K, Huecksteadt TP, Hill K, Sanders K, Karwande SV, Stringham JC, Bull DA, Gleich M, Kennedy TP, and Hoidal JR. Transforming growth factor-beta1 induces Nox4 NAD(P)H oxidase and reactive oxygen species-dependent proliferation in human pulmonary artery smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 290: L661-L673, 2006.
161. Sud N, Wells SM, Sharma S, Wiseman DA, Wilham J, and Black SM. Asymmetric dimethylarginine inhibits HSP90 activity in pulmonary arterial endothelial cells: role of mitochondrial dysfunction. Am J Physiol Cell Physiol 294: C1407-C1418, 2008.
162. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, and Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
163. Tang JR, Markham NE, Lin YJ, McMurtry IF, Maxey A, Kinsella JP, and Abman SH. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am J Physiol Lung Cell Mol Physiol 287: L344- L351, 2004.
164. Teng RJ, Wu TJ, Bisig CG, Eis A, Pritchard KA, and Konduri GG. Nitrotyrosine impairs angiogenesis and uncouples eNOS activity of pulmonary artery endothelial cells isolated from developing sheep lungs. Pediatr Res 69: 112-117, 2011.
165. Thebaud B and Abman SH. Bronchopulmonary dysplasia: where have all the vessels gone? Roles of angiogenic growth factors in chronic lung disease. Am J Respir Crit Care Med 175: 978-985, 2007.
166. Thebaud B, Ladha F, Michelakis ED, Sawicka M, Thurston G, Eaton F, Hashimoto K, Harry G, Haromy A, Korbutt G, and Archer SL. Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization. Circulation 112: 2477-2486, 2005.
167. Tipple TE, Welty SE, Nelin LD, Hansen JM, and Rogers LK. Alterations of the thioredoxin system by hyperoxia: implications for alveolar development. Am J Respir Cell Mol Biol 41: 612-619, 2009.
168. Tourneux P, Chester M, Grover T, and Abman SH. Fasudil inhibits the myogenic response in the fetal pulmonary circulation. Am J Physiol Heart Circ Physiol 295: H1505- H1513, 2008.
169. Traenckner E, Wilk S, and Baeuerle P. A proteasome inhibitor prevents activation of NF-{kappa}B and stabilizes a newly phosphorylated form of I{kappa}B-{alpha} that is still bound to NF-{kappa}B. EMBO J 15: 5433-5441, 1994.
170. Tripathi S and Saili A. The effect of steroids on the clinical course and outcome of neonates with meconium aspiration syndrome. J Trop Pediatr 53: 8-12, 2007.
171. Vadivel A, Aschner JL, Rey-Parra GJ, Magarik J, Zeng H, Summar M, Eaton F, and Thebaud B. L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats. Pediatr Res 68: 519-525, 2010.
172. Van Buul JD, Fernandez-Borja M, Anthony EC, and Hordijk PL. Expression and localization of NOX2 and NOX4 in primary human endothelial cells. Antioxid Redox Signal 7: 308-317, 2005.
173. Van Marter LJ, Leviton A, Allred EN, Pagano M, Sullivan KF, Cohen A, and Epstein MF. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics 97: 658-663, 1996.
174. Veit F, Pak O, Egemnazarov B, Roth M, Kosanovic D, Sommer N, SeimetzM, Ghofrani H, SeegerW, Grimminger F,BrandesRP, Schermuly R, andWeissmannN. Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling. Antioxid Redox Signal 19: 2213-2231, 2013.
175. Villaneuva ME, Zaher FM, Svinarich DM, and Konduri GG. Decreased gene expression of endothelial nitric oxide synthase in newborns with persistent pulmonary hypertension. Pediatr Res 44: 338-343, 1998.
176. Villanueva ME, Zaher FM, Svinarich DM, and Konduri GG. Decreased gene expression of endothelial nitric oxide synthase in newborns with persistent pulmonary hypertension. Pediatr Res 44: 338-343, 1998.
177. Villegas LR, Kluck D, Field C, Oberley-Deegan RE, Woods C, Yeager ME, El Kasmi KC, Savani RC, Bowler RP, and Nozik-Grayck E. Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome. Antioxid Redox Signal 18: 1753-1764, 2013.
178. Wagenaar GT, Laghmani el H, de Visser YP, Sengers RM, Steendijk P, Baelde HJ, and Walther FJ. Ambrisentan reduces pulmonary arterial hypertension but does not stimulate alveolar and vascular development in neonatal rats with hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 304: L264-L275, 2013.
179. Wang Z and Chesler NC. Pulmonary vascular wall stiffness: an important contributor to the increased right ventricular afterload with pulmonary hypertension. Pulm Circ 1: 212-223, 2011.
180. Warner BB, Stuart LA, Papes RA, and Wispe JR. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol 275: L110-L117, 1998.
181. Waypa G, Marks J, Guzy R, Mungai P, Schriewer J, Dokic D, and Schumacker P. Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells. Circ Res 106: 526-535, 2010.
182. Waypa GB, Marks JD, Guzy RD, Mungai PT, Schriewer JM, Dokic D, Ball MK, and Schumacker PT. Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation. Am J Respir Crit Care Med 187: 424-432, 2013.
183. Wedgwood S and Black SM. Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288: L480-L487, 2005.
184. Wedgwood S and Black SM. Induction of apoptosis in fetal pulmonary arterial smooth muscle cells by a combined superoxide dismutase/catalase mimetic. Am J Physiol Lung Cell Mol Physiol 285: L305-L312, 2003.
185. Wedgwood S, Dettman RW, and Black SM. ET-1 stimulates pulmonary arterial smooth muscle cell proliferation via induction of reactive oxygen species. Am J Physiol Lung Cell Mol Physiol 281: L1058-L1067, 2001.
186. Wedgwood S, DeVol J, Grobe A, Benavidez E, Azakie A, Fineman J, and Black S. Fibroblast growth factor-2 expression is altered in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 61: 32-36, 2007.
187. Wedgwood S, Lakshminrusimha S, Czech L, Schumacker PT, and Steinhorn RH. Increased p22phox/Nox4 expression triggers remodeling through hydrogen peroxide signaling in persistent pulmonary hypertension of the newborn. Antioxid Redox Signal 18: 1765-1776, 2013.
188. Wedgwood S, Lakshminrusimha S, Farrow KN, Czech L, Gugino SF, Soares F, Russell JA, and Steinhorn RH. Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 302: L616-L626, 2012.
189. Wedgwood S, Lakshminrusimha S, Fukai T, Russell J, Schumacker P, and Steinhorn R. Hydrogen peroxide regulates extracellular superoxide dismutase activity and expression in neonatal pulmonary hypertension. Antioxid Redox Signal 15: 1497-1506, 2011.
190. Wedgwood S, McMullan DM, Bekker JM, Fineman JR, and Black SM. Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res 89: 357-364, 2001.
191. Wedgwood S, Steinhorn RH, Bunderson M, Wilham J, Lakshminrusimha S, Brennan LA, and Black SM. Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 289: L660-L666, 2005.
192. Wiklund NP, Persson MG, Gustafsson LE, Moncada S, and Hedqvist P. Modulatory role of endogenous nitric oxide in pulmonary circulation in vivo. Eur J Pharmacol 185: 123-124, 1990.
193. Wild LM, Nickerson PA, and Morin III FC. Ligating the ductus arteriosus before birth remodels the pulmonary vasculature of the lamb. Pediatr Res 25: 251-257, 1989.
194. Wong CM, Preston IR, Hill NS, and Suzuki YJ. Iron chelation inhibits the development of pulmonary vascular remodeling. Free Radic Biol Med 53: 1738-1747, 2012.
195. Wright CJ, Zhuang T, La P, Yang G, and Dennery PA. Hyperoxia-induced NF-kappaB activation occurs via a maturationally sensitive atypical pathway. Am J Physiol Lung Cell Mol Physiol 296: L296-L306, 2009.
196. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, and Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
197. Yeh JL, Hsu JH, Dai ZK, Liou SF, Chen IJ, and Wu JR. Increased circulating big endothelin-1, endothelin-1 and atrial natriuretic peptide in infants and children with heart failure secondary to congenital heart disease. Int J Cardiol 104: 15-20, 2005.